Mice transgenically overexpressing human sPLA2-IIA (PLA2G2A-TG) or sPLA2-X (PLA2G10-TG) show striking skin abnormalities characterized by epidermal thickening, sebaceous gland hyperplasia, and alopecia, independently of inflammation [61,62]. Here, PLA2G2A is linked to alopecia.